Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Accumulation of lipotoxic lipids, such as free cholesterol, induces hepatocyte death and subsequent inflammation and fibrosis in the pathogenesis of nonalcoholic steatohepatitis (NASH). However, the underlying mechanisms remain unclear. We have previously reported that hepatocyte death locally induces phenotypic changes in the macrophages surrounding the corpse and remnant lipids, thereby promoting liver fibrosis in a murine model of NASH. Here, we demonstrated that lysosomal cholesterol overload triggers lysosomal dysfunction and profibrotic activation of macrophages during the development of NASH. β-cyclodextrin polyrotaxane (βCD-PRX), a unique supramolecule, is designed to elicit free cholesterol from lysosomes. Treatment with βCD-PRX ameliorated cholesterol accumulation and profibrotic activation of macrophages surrounding dead hepatocytes with cholesterol crystals, thereby suppressing liver fibrosis in a NASH model, without affecting the hepatic cholesterol levels. In vitro experiments revealed that cholesterol-induced lysosomal stress triggered profibrotic activation in macrophages predisposed to the steatotic microenvironment. This study provides evidence that dysregulated cholesterol metabolism in macrophages would be a novel mechanism of NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
Kim, D., Paggi, J. M., Park, C., Bennett, C., & Salzberg, S. L. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0201-4 · Cited by 15,022 · cited 1×
“The reads were mapped to the mm10 reference genome using HISAT2 (Kim et al., 2019) followed by transcript assembly and quantification using StringTie (Pertea et al., 2015).”
MethodGlobal burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249 · cited 1×
“Nonalcoholic fatty liver disease (NAFLD) is a clinical spectrum that encompasses simple steatosis to nonalcoholic steatohepatitis (NASH), the latter of which is considered among the top etiologies for hepatocellular carcinoma and indications for liver transplantation (Younossi et al., 2018, 2019).”
BackgroundEvolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548 · cited 1×
“According to the two-hit or multiple-hit hypothesis, the pathogenesis of NASH involves dysregulated lipid metabolism and inflammatory and profibrotic cues (Tilg and Moschen, 2010).”
BackgroundKimura, S., Noda, T., & Yoshimori, T. (2007) · Autophagy · doi:10.4161/auto.4451 · Cited by 2,278 · cited 1×
“Similar results were obtained using a tandem fluorescence-tagged vector (mRFP-GFP-LC3), which emits both mRFP and GFP signals in autophagosomes and only an mRFP signal in autolysosomes (Kimura et al., 2007; Fig.”
ResultResolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · cited 2×
“Evidence has accumulated regarding the macrophage subsets responsible for the development of liver fibrosis termed SAM, NASH-associated macrophage, and lipid-associated macrophage (Ramachandran et al., 2019; Remmerie et al., 2020; Xiong et al., 2019).”
BackgroundNeuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077 · cited 1×
“The concept of “ lipotoxicity ” has been pointed out that cytotoxic lipids, such as cholesterol, fatty acids, and their metabolites, may directly cause cell death or act in a proinflammatory and profibrotic manner in the pathogenesis of NASH (Neuschwander-Tetri, 2010).”
BackgroundXiong, X., Kuang, H., Ansari, S., Liu, T., Gong, J., Wang, S., Zhao, X.-Y., Ji, Y., Li, C., Guo, L., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.028 · Cited by 784
Remmerie, A., Martens, L., Thoné, T., Castoldi, A., Seurinck, R., Pavie, B., Roels, J., Vanneste, B., De Prijck, S., Vanhockerhout, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.004 · Cited by 592
Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology
Kirkegaard, T., Roth, A. G., Petersen, N. H. T., Mahalka, A. K., Olsen, O. D., Moilanen, I., Zylicz, A., Knudsen, J., Sandhoff, K., Arenz, C., et al. (2010) · Nature · doi:10.1038/nature08710 · Cited by 519 · cited 1×
“For instance, changes in lipid composition, such as cholesterol or sphingosine levels and reactive oxygen species, can lead to increased lysosomal membrane permeabilization (Gómez-Sintes et al., 2016; Kirkegaard et al., 2010).”
BackgroundEnhanced free cholesterol, SREBP-2 and StAR expression in human NASH
Caballero, F., Fernández, A., De Lacy, A. M., Fernández-Checa, J. C., Caballería, J., & García-Ruiz, C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.016 · Cited by 368 · cited 1×
“Lipidomic analysis of human livers revealed that levels of free cholesterol are increased in NASH, while those of esterified cholesterol do not change compared to simple steatosis (Caballero et al., 2009; Van Rooyen et al., 2011).”
Background
Cited by
Updated mechanisms of MASLD pathogenesis
Li, Y., Yang, P., Ye, J., Xu, Q., Wu, J., & Wang, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02108-x · Cited by 300
Immunopathogenic mechanisms and immunoregulatory therapies in MASLD
He, Y., Chen, Y., Qian, S., van Der Merwe, S., Dhar, D., Brenner, D. A., & Tacke, F. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01307-5 · Cited by 81
“Treatment with β CD-PRX effectively mitigated MASH-related liver fi brosis by decreasing cholesterol accumulation and the pro fi brotic activation of macrophages surrounding dead hepatocytes with cholesterol crystals without affecting hepatic and serum levels of cholesterol [62].”
Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy
(2024) · doi:10.1146/annurev-pharmtox-020524-012013 · Cited by 64
Sakuma, I., Gaspar, R. C., Nasiri, A. R., Dufour, S., Kahn, M., Zheng, J., LaMoia, T. E., Guerra, M. T., Taki, Y., Kawashima, Y., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2502978122 · Cited by 46
Metadata
- Authors
- Itoh, M., Tamura, A., Kanai, S., Tanaka, M., Kanamori, Y., Shirakawa, I., Ito, A., Oka, Y., Hidaka, I., Takami, T., Honda, Y., Maeda, M., Saito, Y., Murata, Y., Matozaki, T., Nakajima, A., Kataoka, Y., Ogi, T., Ogawa, Y., & Suganami, T.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2023-09-19
- Volume
- 220
- Issue
- 11
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W4386877581
- Cited by
- 51
- References
- 19
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH. https://app.cochat.ai/papers/10.1084/jem.20220681
- The paper
- Itoh, M., Tamura, A., Kanai, S., Tanaka, M., Kanamori, Y., Shirakawa, I., Ito, A., Oka, Y., Hidaka, I., Takami, T., Honda, Y., Maeda, M., Saito, Y., Murata, Y., Matozaki, T., Nakajima, A., Kataoka, Y., Ogi, T., Ogawa, Y., & Suganami, T. (2023). Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20220681
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.